175 related articles for article (PubMed ID: 28870792)
1. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.
Gutin PH; Iwamoto FM; Beal K; Mohile NA; Karimi S; Hou BL; Lymberis S; Yamada Y; Chang J; Abrey LE
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):156-63. PubMed ID: 19167838
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse.
Tong E; Horsley P; Wheeler H; Wong M; Venkatesha V; Chan J; Kastelan M; Back M
J Neurooncol; 2024 May; 168(1):69-76. PubMed ID: 38551747
[TBL] [Abstract][Full Text] [Related]
4. Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
Pollom EL; Fujimoto D; Wynne J; Seiger K; Modlin LA; Jacobs LR; Azoulay M; von Eyben R; Tupper L; Gibbs IC; Hancock SL; Li G; Chang SD; Adler JR; Harsh GR; Harraher C; Nagpal S; Thomas RP; Recht LD; Choi CYH; Soltys SG
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):123-130. PubMed ID: 28586949
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.
Yilmaz MT; Kahvecioglu A; Yazici G; Mohammadipour S; Kertmen N; Cifci GC; Zorlu F
J Neurooncol; 2024 Apr; 167(2):295-303. PubMed ID: 38383875
[TBL] [Abstract][Full Text] [Related]
6. Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review.
Ajithkumar T; Avanzo M; Yorke E; Tsang DS; Milano MT; Olch AJ; Merchant TE; Dieckmann K; Mahajan A; Fuji H; Paulino AC; Timmermann B; Marks LB; Bentzen SM; Jackson A; Constine LS
Int J Radiat Oncol Biol Phys; 2024 Jun; 119(2):655-668. PubMed ID: 38300187
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience.
Ciammella P; Podgornii A; Galeandro M; D'Abbiero N; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
Radiat Oncol; 2013 Sep; 8():222. PubMed ID: 24066926
[TBL] [Abstract][Full Text] [Related]
9. Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study.
Laterra JJ; Grossman SA; Carson KA; Lesser GJ; Hochberg FH; Gilbert MR;
Neuro Oncol; 2004 Jan; 6(1):15-20. PubMed ID: 14769135
[TBL] [Abstract][Full Text] [Related]
10. Reverse swing-M, phase 1 study of repurposing mebendazole in recurrent high-grade glioma.
Patil VM; Bhelekar A; Menon N; Bhattacharjee A; Simha V; Abhinav R; Abhyankar A; Sridhar E; Mahajan A; Puranik AD; Purandare N; Janu A; Ahuja A; Krishnatry R; Gupta T; Jalali R
Cancer Med; 2020 Jul; 9(13):4676-4685. PubMed ID: 32400117
[TBL] [Abstract][Full Text] [Related]
11. Promising outcome of patients with recurrent glioblastoma after Gamma Knife-based hypofractionated radiotherapy.
Hatiboglu MA; Akdur K; Sakarcan A; Seyithanoglu MH; Turk HM; Sinclair G; Oztanir MN
Neurochirurgie; 2024 Mar; 70(2):101532. PubMed ID: 38215936
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience.
Clark GM; McDonald AM; Nabors LB; Fathalla-Shaykh H; Han X; Willey CD; Markert JM; Guthrie BL; Bredel M; Fiveash JB
Neurooncol Pract; 2014 Dec; 1(4):172-177. PubMed ID: 26034629
[TBL] [Abstract][Full Text] [Related]
13. Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial.
Derby S; Jackson MR; Williams K; Stobo J; Kelly C; Sweeting L; Shad S; Herbert C; Short SC; Williamson A; James A; Nowicki S; Bulbeck H; Chalmers AJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1371-1378. PubMed ID: 38211641
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6.
Zalutsky MR; Reardon DA; Akabani G; Coleman RE; Friedman AH; Friedman HS; McLendon RE; Wong TZ; Bigner DD
J Nucl Med; 2008 Jan; 49(1):30-8. PubMed ID: 18077533
[TBL] [Abstract][Full Text] [Related]
15. Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.
Thompson EM; Landi D; Brown MC; Friedman HS; McLendon R; Herndon JE; Buckley E; Bolognesi DP; Lipp E; Schroeder K; Becher OJ; Friedman AH; McKay Z; Walter A; Threatt S; Jaggers D; Desjardins A; Gromeier M; Bigner DD; Ashley DM
Lancet Child Adolesc Health; 2023 Jul; 7(7):471-478. PubMed ID: 37004712
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice.
Montay-Gruel P; Acharya MM; Gonçalves Jorge P; Petit B; Petridis IG; Fuchs P; Leavitt R; Petersson K; Gondré M; Ollivier J; Moeckli R; Bochud F; Bailat C; Bourhis J; Germond JF; Limoli CL; Vozenin MC
Clin Cancer Res; 2021 Feb; 27(3):775-784. PubMed ID: 33060122
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma.
Sheehan JP; Mantziaris G; Bunevicius A
J Neurooncol; 2024 Mar; 167(1):231-232. PubMed ID: 38363492
[No Abstract] [Full Text] [Related]
18. Long-Term Results of a Phase 1 Dose Escalation Trial of Ablative Stereotactic Body Radiation Therapy.
Mercier C; Billiet C; Ost P; Joye I; Meijnders P; Vermeulen P; Dirix L; Verellen D; Dirix P
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1490-1496. PubMed ID: 38151189
[TBL] [Abstract][Full Text] [Related]
19. ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma.
Pepper NB; Eich HT; Müther M; Oertel M; Rehn S; Spille DC; Stummer W
Radiat Oncol; 2024 Jan; 19(1):11. PubMed ID: 38254201
[TBL] [Abstract][Full Text] [Related]
20. Validation of Combs prognostic scoring system in Indian recurrent glioma patients treated with re-radiation.
Dutta D; Jose M; Kalavagunta S; Sasidharan A; Nair H; Edappattu AH
Radiat Oncol J; 2024 Mar; 42(1):32-42. PubMed ID: 38549382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]